YBX1 and breast cancer: The first cohort, the TCGA PanCancer BC cohort, which contains clinical information on 1082 BC patients, including 181 TNBCs (Table 1), showed a significant (p < 0.0001) positive association between YB1 expression levels and the basal (TNBC) BC subtype (Figure 1A).